Taylor Frigon Capital Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
CC
Taylor Frigon Capital Management's PRCT Position: Q2 2026 in Review
Taylor Frigon Capital Management increased its Procept Biorobotics (PRCT) stake by 15% in Q2 2026, buying an estimated $322K and bringing the position to 101,572 shares worth $2.29M. The position accounts for 1.07% of the portfolio, ranked #40.
Taylor Frigon Capital Management first reported a position in PRCT in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.95M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.
- Taylor Frigon Capital Management held 101,572 shares of Procept Biorobotics worth $2.29M as of Q2 2026.
- Taylor Frigon Capital Management bought 12,864 Procept Biorobotics shares in Q2 2026, an estimated $322K.
- Procept Biorobotics made up 1.07% of Taylor Frigon Capital Management's portfolio in Q2 2026, its #40 holding.
- Taylor Frigon Capital Management first reported a position in Procept Biorobotics in Q3 2022 and has held it in 16 quarters since.
- Taylor Frigon Capital Management's Procept Biorobotics position peaked at $5.95M in Q3 2024.
- 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.
Based on Taylor Frigon Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.